The role of liver kinase B1 in tumor progression through regulation of lipid metabolism Jialu GengYanghe ZhangYishu Wang Review Article Open access 27 July 2022 Pages: 2045 - 2054
MiRNAs in renal cell carcinoma Jesús Miranda-PomaLucía Trilla-FuertesÁlvaro Pinto-Marín Review Article 21 June 2022 Pages: 2055 - 2063
AMPK’s double-faced role in advanced stages of prostate cancer Faeze GharibpoorSara Kamali ZonouziNima Rezaei Review Article 04 July 2022 Pages: 2064 - 2073
Colorectal cancer-derived exosomes and modulation KRAS signaling Yan Hua WanQi Sheng LiuRi Wei Wang Review Article 05 July 2022 Pages: 2074 - 2080
Long non-coding RNA signatures and related signaling pathway in T-cell acute lymphoblastic leukemia Homayon YousefiDaryush PurrahmanMohammad-Reza Mahmoudian-Sani Review Article 19 July 2022 Pages: 2081 - 2089
Bone loss induced by cancer treatments in breast and prostate cancer patients Santos CastañedaAna CasasÁlvaro Rodríguez-Lescure Special Article Open access 02 July 2022 Pages: 2090 - 2106
Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer Ruth VeraCarolina Ibarrola-de-AndrésBeatriz Madrigal-Rubiales Special Article Open access 25 August 2022 Pages: 2107 - 2119
CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer Chih-Yi LinChung-Jen YuJiun-I. Lai Research Article 02 August 2022 Pages: 2120 - 2135
Effect of cell density on the malignant biological behavior of breast cancer by altering the subcellular localization of ANXA2 and its clinical implications Jingtai ChenXiaohan SuYanchun Gao Research Article 01 July 2022 Pages: 2136 - 2145
Timing of radiotherapy in glioblastoma based on IMRT and STUPP chemo-radiation: may be no need to rush Shan LiFeibao GuoJinsheng Hong Research Article 26 June 2022 Pages: 2146 - 2154
Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01) Jorge AparicioAnna C. Virgili ManriqueJoan Maurel Research Article Open access 27 June 2022 Pages: 2155 - 2165
BMI1 promotes the proliferation and inhibits autophagy of breast cancer cells by activating COPZ1 Shuming ChenHe LiKaixiang Zhang Research Article 04 July 2022 Pages: 2166 - 2174
Prognostic value of transcriptional expression of fibronectin type III domain-containing 4 (FNDC4) in head and neck carcinoma patients treated with chemoradiotherapy Mercedes CamachoXavier LeónJacinto García Research Article 25 June 2022 Pages: 2175 - 2180
Characteristics of gut microbiota in patients with gastric cancer by surgery, chemotherapy and lymph node metastasis Changchang ChenJian ShenLijun Lin Research Article 06 July 2022 Pages: 2181 - 2190
Expression pattern and clinical significance of beta 2-adrenergic receptor in oral squamous cell carcinoma: an emerging prognostic indicator and future therapeutic target Akhilesh KrishnaVineeta SinghRakesh Kumar Singh Research Article 02 August 2022 Pages: 2191 - 2199
The application value of CDFI and SMI combined with serological markers in distinguishing benign and malignant thyroid nodules Fang LiWei SunJianli Su Research Article 06 July 2022 Pages: 2200 - 2209
Resveratrol inhibits TGF-β1-induced EMT in gastric cancer cells through Hippo-YAP signaling pathway Lei DengJun ZouLianwu Zhao Research Article 17 July 2022 Pages: 2210 - 2221
IL-6 secretion of CD4+ T cells stimulated by LC3-positive extracellular vesicles in human epithelial ovarian cancer Xiu-Lin ZhuHao-Jue WangYun-lang Cai Research Article 23 July 2022 Pages: 2222 - 2230
Establishment of an acquired lorlatinib-resistant cell line of non-small cell lung cancer and its mediated resistance mechanism Bo XieYing QiuWeimin Zhang Research Article 19 July 2022 Pages: 2231 - 2240
Excess weight and anti-PD-1 immune checkpoint inhibitor’s outcomes in non-small cell lung cancer Jacobo RogadoFernando PozoRamon Colomer Research Article 23 July 2022 Pages: 2241 - 2249
Correction to: Bone loss induced by cancer treatments in breast and prostate cancer patients Santos CastañedaAna CasasÁlvaro Rodríguez-Lescure Correction Open access 06 August 2022 Pages: 2250 - 2250
Correction to: CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer Chih-Yi LinChung-Jen YuJiun-I. Lai Correction 10 September 2022 Pages: 2251 - 2253